⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AVBP News
ArriVent BioPharma, Inc. Common Stock
$207B Market Shift: The Race for Fast Track Approval in Oncology
prnewswire.com
AVBP
ONCY
RLAY
ZLAB
MAIA
Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026
prnewswire.com
ONCY
CGON
ZNTL
AVBP
PDSB
ArriVent Announces First Patient Dosed in Global Pivotal Phase 3 ALPACCA Trial Evaluating Firmonertinib for First-Line Treatment of EGFR PACC Mutant Non-Small Cell Lung Cancer
globenewswire.com
AVBP
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B
prnewswire.com
ONCY
AVBP
MRUS
HALO
AIM